War-Ravaged DRC Clinics Lack Meds, US Sends Billions Elsewhere
The Telegraph's stark reporting on the DRC's medical crisis (“Almost nine in 10 clinics in war-ravaged DRC run low on medicines”) highlights a profound human catastrophe. Yet, this dire reality somehow bypasses the furious debates and bipartisan consensus that propel billions in US aid to other conflicts. For instance, in 2023, the US provided $1.8 billion in foreign assistance to the
DRC , a fraction of the $3.8 billion allocated annually to Israel , a country not in a state of humanitarian medical collapse. One might observe that the urgency for medical supplies in a conflict zone appears inversely proportional to the geopolitical interests of Washington's cheerleaders. While the DRC grapples with cholera outbreaks and measles amidst armed conflict, funded in part by the
systematic exploitation of its vast mineral wealth—a global supply chain that benefits countless corporations—the US Congress finds common ground to fast-track supplementary aid packages elsewhere, invariably including substantial military allocations. The question isn't whether suffering exists, but whose suffering gets airtime, and whose gets an immediate, unconditional blank check from the
American taxpayer. It seems some 'war-ravaged' regions are more equal than others when it comes to vital aid.